SDGR: Schrödinger, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,203.39
Enterprise Value ($M) 1,056.06
Book Value ($M) 421.44
Book Value / Share 6.60
Price / Book 2.86
NCAV ($M) 233.21
NCAV / Share 3.65
Price / NCAV 5.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.25
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 3.31
Current Ratio 3.31

Balance Sheet (mrq) ($M)
Current Assets 634.99
Assets 823.23
Liabilities 401.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 207.54
Operating Income -209.30
Net Income -187.12

Cash Flow Statement (mra) ($M)
Cash From Operations -157.37
Cash from Investing 148.84
Cash from Financing 10.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Rubric Capital Management LP 7.85 35.67
02-04 13G Sumitomo Mitsui Trust Holdings, Inc. 5.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 204,661 713,050 28.70
2025-04-01 315,603 1,019,790 30.95
2025-03-31 152,638 682,116 22.38
2025-03-28 99,395 550,797 18.05

(click for more detail)

Similar Companies
RXRX – Recursion Pharmaceuticals, Inc. SANA – Sana Biotechnology, Inc.
SCPH – scPharmaceuticals Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc.


Financial data and stock pages provided by
Fintel.io